Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Circulating tumor DNA in cancer diagnosis, monitoring, and prognosis.

Journal of the Egyptian National Cancer Institute - 21 Feb 2022

Saha Sudeepto, Araf Yusha, Promon Salman Khan

Abstract excerpt

BACKGROUND: Circulating tumor DNA (ctDNA) has become one of the crucial components for cancer detection with the increase of precision medicine practice. ctDNA has great potential as a blood-based biomarker for the detection and treatment of cancer in its early stages. The purpose of this article was to discuss ctDNA and how it can be utilized to detect cancer. The benefits and drawbacks of this cancer detection...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Circulating Tumor DNA
Share to DNA, Neoplasm

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to High-Throughput Nucleotide Sequencing

Share to Mutation

Share to Neoplasms

Share to Prognosis

Source

Open in PubMed Open full text

Identifiers

PMID: 35187602
DOI: 10.1186/s43046-022-00109-4
PMCID: PMC13314305

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Circulating tumor DNA in cancer diagnosis, monitoring, and prognosis.PMID 35187602Read ↗

Circulating Tumor DNA as Biomarkers for Cancer DetectionSemantic proximity Read ↗

Circulating tumor DNA analysis for tumor diagnosis.Semantic proximity Read ↗

Circulating Tumor DNA—A Novel Biomarker of Tumor Progression and Its Favorable Detection TechniquesSemantic proximity Read ↗

Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancer.Semantic proximity Read ↗

Revolution of Circulating Tumor DNA: From Bench Innovations to Bedside ImplementationsSemantic proximity Read ↗

Circulating Tumor DNA in Cancer Management.Semantic proximity Read ↗

Circulating Tumor DNA Assays in Clinical Cancer ResearchSemantic proximity Read ↗

Recent Advancements in the Application of Circulating Tumor DNA as Biomarkers for Early Detection of CancersSemantic proximity Read ↗

The feasibility of using mutation detection in ctDNA to assess tumor dynamics.Semantic proximity Read ↗

Circulating tumor DNA in blood: Future genomic biomarkers for cancer detectionSemantic proximity Read ↗

Circulating Tumor DNA as a Cancer Biomarker: An Overview of Biological Features and Factors That may Impact on ctDNA AnalysisSemantic proximity Read ↗

ctDNA as a Cancer Biomarker: A Broad OverviewSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.